Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Non-controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ending balance (in shares)				92,490,768
Beginning balance (in shares) at Dec. 31, 2020			23,219,613
Beginning balance at Dec. 31, 2020	$ 622,948		$ 406,665	$ 9	$ 853,824		$ 0	$ (626,456)			$ (11,094)
Beginning balance (in shares) at Dec. 31, 2020				92,490,768
Beginning balance (in shares) at Dec. 31, 2020							(800,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of series AA preferred stock (in shares)			23,219,613	46,439,226
Conversion of Series AA Preferred Stock	0		$ (406,665)	$ 5	406,660
Exercise of common stock warrants (in shares)				536,825
Exercise of common stock warrants	15,803				15,803
Recognition of debt discount on 2026 Convertible Notes	88,059				88,059
Exercise of stock options (in shares)				1,082,964
Exercise of stock options	776				776
Issuance of treasury stock in connection with acquisition (in shares)							623,068
Issuance of treasury stock in connection with acquisition	8,538				8,538
Stock-based compensation	9,374				9,374
Other	(5)				(5)
Less: net loss attributable to non-controlling interest	(76)										(76)
Net loss	(70,110)							(70,110)
Ending balance (in shares) at Mar. 31, 2021			0
Ending balance at Mar. 31, 2021	675,307		$ 0	$ 14	1,383,029		$ 0	(696,566)			(11,170)
Ending balance (in shares) at Mar. 31, 2021							(176,932)
Beginning balance (in shares) at Dec. 31, 2020			23,219,613
Beginning balance at Dec. 31, 2020	622,948		$ 406,665	$ 9	853,824		$ 0	(626,456)			(11,094)
Beginning balance (in shares) at Dec. 31, 2020				92,490,768
Beginning balance (in shares) at Dec. 31, 2020							(800,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Less: net loss attributable to non-controlling interest	(91)
Net loss	(165,025)
Ending balance (in shares) at Jun. 30, 2021			0
Ending balance at Jun. 30, 2021	606,397		$ 0	$ 14	1,409,049		$ 0	(791,481)			(11,185)
Ending balance (in shares) at Jun. 30, 2021							(176,932)
Beginning balance (in shares) at Dec. 31, 2020			23,219,613
Beginning balance at Dec. 31, 2020	622,948		$ 406,665	$ 9	853,824		$ 0	(626,456)			(11,094)
Beginning balance (in shares) at Dec. 31, 2020				92,490,768
Beginning balance (in shares) at Dec. 31, 2020							(800,000)
Ending balance at Dec. 31, 2021	$ 670,881	$ (75,264)		$ 16	1,691,206	$ (87,946)		(1,009,293)	$ 12,682	$ 172	(11,220)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	Accounting Standards Update 2020-06 [Member]
Ending balance (in shares)				140,549,783
Beginning balance (in shares) at Mar. 31, 2021			0
Beginning balance at Mar. 31, 2021	$ 675,307		$ 0	$ 14	1,383,029		$ 0	(696,566)			(11,170)
Beginning balance (in shares) at Mar. 31, 2021				140,549,783
Beginning balance (in shares) at Mar. 31, 2021							(176,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock warrants (in shares)				71,428
Exercise of common stock warrants	500				500
Recognition of debt discount on 2026 Convertible Notes	(113)				(113)
Exercise of stock options (in shares)				508,664
Exercise of stock options	1,200				1,200
Stock-based compensation	24,431				24,431
Other (in shares)				(32,581)
Other	2				2
Less: net loss attributable to non-controlling interest	(15)										(15)
Net loss	(94,915)							(94,915)
Ending balance (in shares) at Jun. 30, 2021			0
Ending balance at Jun. 30, 2021	$ 606,397		$ 0	$ 14	1,409,049		$ 0	(791,481)			(11,185)
Ending balance (in shares) at Jun. 30, 2021							(176,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ending balance (in shares)				141,097,294
Ending balance (in shares)	153,950,895			153,950,895
Beginning balance at Dec. 31, 2021	$ 670,881	(75,264)		$ 16	1,691,206	(87,946)		(1,009,293)	12,682	172	(11,220)
Beginning balance (in shares) at Dec. 31, 2021	153,950,895			153,950,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock/At-the-market offering, net of offering costs (in shares)				27,443,580
Issuance of common stock/At-the-market offering, net of offering costs	$ 203,796			$ 2	203,794
Exercise of common stock warrants (in shares)				540,541
Exercise of common stock warrants	10,249				10,249
Exercise of stock options (in shares)				349,847
Exercise of stock options	443				443
Delivery of common stock underlying restricted stock units (in shares)				392,326
Stock-based compensation	19,449				19,449
Foreign currency translation adjustment	(2,215)									(2,215)
Less: net loss attributable to non-controlling interest	(93)										(93)
Net loss	(140,724)							(140,724)
Ending balance at Mar. 31, 2022	686,522			$ 18	1,837,195			(1,137,335)		(2,043)	(11,313)
Beginning balance at Dec. 31, 2021	$ 670,881	$ (75,264)		$ 16	1,691,206	$ (87,946)		(1,009,293)	$ 12,682	172	(11,220)
Beginning balance (in shares) at Dec. 31, 2021	153,950,895			153,950,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	430,122
Less: net loss attributable to non-controlling interest	$ (243)
Net loss	(256,848)
Ending balance at Jun. 30, 2022	600,134			$ 19	1,867,924			(1,253,459)		(2,887)	(11,463)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ending balance (in shares)				182,677,189
Beginning balance at Mar. 31, 2022	$ 686,522			$ 18	1,837,195			(1,137,335)		(2,043)	(11,313)
Beginning balance (in shares) at Mar. 31, 2022				182,677,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock/At-the-market offering, net of offering costs (in shares)	16,392,000			2,400,000
Issuance of common stock/At-the-market offering, net of offering costs				$ 1	16,391
Exercise of stock options (in shares)				80,275
Exercise of stock options	$ 129				129
Stock-based compensation	14,209				14,209
Foreign currency translation adjustment	(844)									(844)
Less: net loss attributable to non-controlling interest	(150)										(150)
Net loss	(116,124)							(116,124)		0
Ending balance at Jun. 30, 2022	$ 600,134			$ 19	$ 1,867,924			$ (1,253,459)		$ (2,887)	$ (11,463)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ending balance (in shares)	185,293,067			185,293,067